首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 孙剑
2024
CA
Serum hepatitis B virus spliced RNA proportion increases with liver disease progression in patients with chronic hepatitis B
J MED VIROL, 10.1002/jmv.29400
CA
Polyethylene Terephthalate Hydrolases in Human Gut Microbiota and Their Implications for Human Health
Microorganisms, 10.3390/microorganisms12010138
2023
Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis
Hepatology, 10.1097/HEP.0000000000000654
CA
Which Is More Clinically Relevant: End-of-Treatment or Off-Treatment Predictors of Hepatitis B Relapse and Surface Antigen Loss?
Gastroenterology, 10.1053/j.gastro.2023.10.020
CA
Conditional replication and secretion of hepatitis B virus genome uncover the truncated 3' terminus of encapsidated viral pregenomic RNA
J VIROL, 10.1128/jvi.00760-23
CA
Various ambient air pollutants, residential green spaces, fibrosis 4 scores, genetic susceptibility, and risk of severe liver disease
EES, 10.1016/j.ecoenv.2023.115246
CA
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures
J HEPATOL, 10.1016/j.jhep.2023.05.039
CA
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B
J MED VIROL, 10.1002/jmv.28501
2022
FA
CA
The changing epidemiology of liver diseases in Asia
Liver Int, 10.1111/liv.15354
CA
Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts
Front Immunol, 10.3389/fimmu.2022.868809
CA
[Expert consensus on measurement and clinical application of serum HBV RNA in patients with chronic HBV infection]
Zhonghua ganzangbing zazhi, 10.3760/cma.j.cn501113-20220420-00214
CA
Probability of HBsAg loss after nucleos(t)ide analogue withdrawal depends on HBV genotype and viral antigen levels
J HEPATOL, 10.1016/j.jhep.2022.04.022
CA
Circulating HBV RNA: From biology to clinical applications
Hepatology, 10.1002/hep.32479
CA
Advances in new antivirals for chronic hepatitis B
Chin Med J, 10.1097/CM9.0000000000001994
2021
CA
Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy
JID, 10.1093/infdis/jiab597
CA
Metabolic Defects of Peripheral T Cells in COVID-19 Patients
J Immun, 10.4049/jimmunol.2100068
CA
Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients
ANTIVIR RES, 10.1016/j.antiviral.2021.105037
CA
Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia
Genomics, 10.1016/j.ygeno.2021.01.026
2020
CA
Letter to the Editor: Can the Ratio of Serum HBV RNA to DNA Reflect the Reverse-Transcription Efficiency of Viral pgRNA?
Hepatology, 10.1002/hep.31691